APOLLOHOSP - IntraDay Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

IntraDay Trade Rating: 3.8

🩺 Intraday Trading Analysis for APOLLOHOSP (Apollo Hospitals Enterprise Ltd.)

Apollo Hospitals shows moderate potential for intraday trading today. While the stock is in a longer-term uptrend and has strong quarterly earnings growth, its high valuation, slowing volume, and neutral momentum indicators suggest caution for aggressive intraday positions.

🔍 Key Technical & Fundamental Highlights

⚖️ Mixed Technicals

RSI at 57.9: Neutral zone — neither overbought nor oversold.

MACD at 57.9: Mild bullish signal — but not strongly trending.

Current Price ₹7,456 > DMA50 ₹7,201 and DMA200 ₹6,890: Positive trend continuation.

Volume Today (3.53L) < Avg Vol 1Wk (4.13L): Slight volume drop — weak intraday conviction.

52w Index at 89.0%: Near yearly highs — limited upside without breakout.

✅ Strong Fundamentals

ROCE 17.1% & ROE 19.1%: Solid efficiency for a healthcare major.

EPS ₹101 vs. P/E 74.1: Overvalued — premium pricing.

PEG Ratio 3.79: Expensive relative to growth.

Debt-to-Equity 0.96: High leverage — riskier balance sheet.

PAT Qtr ₹390 Cr vs. Prev Qtr ₹372 Cr: Consistent growth.

Qtr Profit Var +53.5%: Strong YoY performance.

FII Holding Change +0.75%: Positive foreign sentiment.

DII Holding Change -0.95%: Mild domestic reduction.

🛒 Optimal Buy Price for Intraday

Buy Zone: ₹7,440–₹7,460 Entry only if price sustains above ₹7,450 with volume picking up above 4.5L and RSI rising toward 60.

🎯 Exit Strategy

Profit-Taking Levels

Target 1: ₹7,520 — minor resistance

Target 2: ₹7,580 — near recent high

Stop-Loss / Loss Protection

Stop-Loss: ₹7,410 — below intraday support and psychological ₹7,400 level

📉 If You Already Hold the Stock Today

Exit on Weakness

RSI drops below 55 or MACD flattens

Price fails to hold above ₹7,450 post 2:00 PM IST

Volume Watch

If volume remains below 4L and price stalls near ₹7,470, consider partial exit

Momentum Exit Strategy

If price hits ₹7,580+, trail stop-loss upward by ₹30–₹40 increments

Exit fully if price reverses sharply from ₹7,600 with rising sell volume

Would you like a comparison with other healthcare stocks showing stronger intraday setups or lower PEG ratios for better short-term value?

Edit in a page